There are 805 resources available
89P - Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Presenter: Qingyan Au
Session: Poster Display session
Resources:
Abstract
90P - Intensity-modulated radiation therapy can reduce acute toxicities in long-course neoadjuvant radiation therapy combined with S-1 for locally advanced rectal cancer
Presenter: Saori Tatsuno
Session: Poster Display session
Resources:
Abstract
91P - Clinicopathological and molecular features of claudin-18 isoform 2 in pathological stage I–III colorectal cancer
Presenter: Shigemasa Takamizawa
Session: Poster Display session
Resources:
Abstract
92P - Clinical and mutational landscape of geriatric colorectal carcinoma: A real-world data analysis from the GENIE database
Presenter: Yostena Mekhail
Session: Poster Display session
Resources:
Abstract
93P - FOLFIRI plus bevacizumab versus FOLFIRI plus ramucirumab as second-line chemotherapy for metastatic colorectal cancer in the real-world
Presenter: Takaya Shimura
Session: Poster Display session
Resources:
Abstract
94P - Enhanced recovery after surgery (ERAS) protocols in vietnamese colon cancer
Presenter: Thao Nguyen
Session: Poster Display session
Resources:
Abstract
95P - ADAR1 of T cells rather than epitheliums contributes the bulk expression and induces immune exhaustion in colorectal cancer
Presenter: Rongxin Zhang
Session: Poster Display session
Resources:
Abstract
96P - Liposomal irinotecan + 5-FU/LV + bevacizumab for second-line treatment of metastatic colorectal cancer (IRIS): A prospective, multi-center, single-arm clinical study
Presenter: Xuhua Hu
Session: Poster Display session
Resources:
Abstract
97P - Study on monitoring ripretinib and its metabolites plasma concentration in Chinese patients with gastrointestinal stromal tumors
Presenter: Hao Xu
Session: Poster Display session
Resources:
Abstract
98P - Real-world evidence on total neoadjuvant therapy (TNT) vs neoadjuvant concurrent chemoradiation (NA CCRT) for locally advanced rectal cancer (LARC) from a Tertiary Asian Cancer Centre
Presenter: Meng Wang
Session: Poster Display session
Resources:
Abstract